Cargando…

Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Theileria parva Infected Cells

The apicomplexan parasite Theileria parva is the causative agent of East Coast fever, usually a fatal disease for cattle, which is prevalent in large areas of eastern, central, and southern Africa. Protective immunity against T. parva is mediated by CD8(+) T cells, with CD4(+) T-cells thought to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Connelley, Timothy, Nicastri, Annalisa, Sheldrake, Tara, Vrettou, Christina, Fisch, Andressa, Reynisson, Birkir, Buus, Soren, Hill, Adrian, Morrison, Ivan, Nielsen, Morten, Ternette, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699068/
https://www.ncbi.nlm.nih.gov/pubmed/36423003
http://dx.doi.org/10.3390/vaccines10111907
_version_ 1784838978065661952
author Connelley, Timothy
Nicastri, Annalisa
Sheldrake, Tara
Vrettou, Christina
Fisch, Andressa
Reynisson, Birkir
Buus, Soren
Hill, Adrian
Morrison, Ivan
Nielsen, Morten
Ternette, Nicola
author_facet Connelley, Timothy
Nicastri, Annalisa
Sheldrake, Tara
Vrettou, Christina
Fisch, Andressa
Reynisson, Birkir
Buus, Soren
Hill, Adrian
Morrison, Ivan
Nielsen, Morten
Ternette, Nicola
author_sort Connelley, Timothy
collection PubMed
description The apicomplexan parasite Theileria parva is the causative agent of East Coast fever, usually a fatal disease for cattle, which is prevalent in large areas of eastern, central, and southern Africa. Protective immunity against T. parva is mediated by CD8(+) T cells, with CD4(+) T-cells thought to be important in facilitating the full maturation and development of the CD8(+) T-cell response. T. parva has a large proteome, with >4000 protein-coding genes, making T-cell antigen identification using conventional screening approaches laborious and expensive. To date, only a limited number of T-cell antigens have been described. Novel approaches for identifying candidate antigens for T. parva are required to replace and/or complement those currently employed. In this study, we report on the use of immunopeptidomics to study the repertoire of T. parva peptides presented by both BoLA-I and BoLA-DR molecules on infected cells. The study reports on peptides identified from the analysis of 13 BoLA-I and 6 BoLA-DR datasets covering a range of different BoLA genotypes. This represents the most comprehensive immunopeptidomic dataset available for any eukaryotic pathogen to date. Examination of the immunopeptidome data suggested the presence of a large number of coprecipitated and non-MHC-binding peptides. As part of the work, a pipeline to curate the datasets to remove these peptides was developed and used to generate a final list of 74 BoLA-I and 15 BoLA-DR-presented peptides. Together, the data demonstrated the utility of immunopeptidomics as a method to identify novel T-cell antigens for T. parva and the importance of careful curation and the application of high-quality immunoinformatics to parse the data generated.
format Online
Article
Text
id pubmed-9699068
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96990682022-11-26 Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Theileria parva Infected Cells Connelley, Timothy Nicastri, Annalisa Sheldrake, Tara Vrettou, Christina Fisch, Andressa Reynisson, Birkir Buus, Soren Hill, Adrian Morrison, Ivan Nielsen, Morten Ternette, Nicola Vaccines (Basel) Article The apicomplexan parasite Theileria parva is the causative agent of East Coast fever, usually a fatal disease for cattle, which is prevalent in large areas of eastern, central, and southern Africa. Protective immunity against T. parva is mediated by CD8(+) T cells, with CD4(+) T-cells thought to be important in facilitating the full maturation and development of the CD8(+) T-cell response. T. parva has a large proteome, with >4000 protein-coding genes, making T-cell antigen identification using conventional screening approaches laborious and expensive. To date, only a limited number of T-cell antigens have been described. Novel approaches for identifying candidate antigens for T. parva are required to replace and/or complement those currently employed. In this study, we report on the use of immunopeptidomics to study the repertoire of T. parva peptides presented by both BoLA-I and BoLA-DR molecules on infected cells. The study reports on peptides identified from the analysis of 13 BoLA-I and 6 BoLA-DR datasets covering a range of different BoLA genotypes. This represents the most comprehensive immunopeptidomic dataset available for any eukaryotic pathogen to date. Examination of the immunopeptidome data suggested the presence of a large number of coprecipitated and non-MHC-binding peptides. As part of the work, a pipeline to curate the datasets to remove these peptides was developed and used to generate a final list of 74 BoLA-I and 15 BoLA-DR-presented peptides. Together, the data demonstrated the utility of immunopeptidomics as a method to identify novel T-cell antigens for T. parva and the importance of careful curation and the application of high-quality immunoinformatics to parse the data generated. MDPI 2022-11-11 /pmc/articles/PMC9699068/ /pubmed/36423003 http://dx.doi.org/10.3390/vaccines10111907 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Connelley, Timothy
Nicastri, Annalisa
Sheldrake, Tara
Vrettou, Christina
Fisch, Andressa
Reynisson, Birkir
Buus, Soren
Hill, Adrian
Morrison, Ivan
Nielsen, Morten
Ternette, Nicola
Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Theileria parva Infected Cells
title Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Theileria parva Infected Cells
title_full Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Theileria parva Infected Cells
title_fullStr Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Theileria parva Infected Cells
title_full_unstemmed Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Theileria parva Infected Cells
title_short Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Theileria parva Infected Cells
title_sort immunopeptidomic analysis of bola-i and bola-dr presented peptides from theileria parva infected cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699068/
https://www.ncbi.nlm.nih.gov/pubmed/36423003
http://dx.doi.org/10.3390/vaccines10111907
work_keys_str_mv AT connelleytimothy immunopeptidomicanalysisofbolaiandboladrpresentedpeptidesfromtheileriaparvainfectedcells
AT nicastriannalisa immunopeptidomicanalysisofbolaiandboladrpresentedpeptidesfromtheileriaparvainfectedcells
AT sheldraketara immunopeptidomicanalysisofbolaiandboladrpresentedpeptidesfromtheileriaparvainfectedcells
AT vrettouchristina immunopeptidomicanalysisofbolaiandboladrpresentedpeptidesfromtheileriaparvainfectedcells
AT fischandressa immunopeptidomicanalysisofbolaiandboladrpresentedpeptidesfromtheileriaparvainfectedcells
AT reynissonbirkir immunopeptidomicanalysisofbolaiandboladrpresentedpeptidesfromtheileriaparvainfectedcells
AT buussoren immunopeptidomicanalysisofbolaiandboladrpresentedpeptidesfromtheileriaparvainfectedcells
AT hilladrian immunopeptidomicanalysisofbolaiandboladrpresentedpeptidesfromtheileriaparvainfectedcells
AT morrisonivan immunopeptidomicanalysisofbolaiandboladrpresentedpeptidesfromtheileriaparvainfectedcells
AT nielsenmorten immunopeptidomicanalysisofbolaiandboladrpresentedpeptidesfromtheileriaparvainfectedcells
AT ternettenicola immunopeptidomicanalysisofbolaiandboladrpresentedpeptidesfromtheileriaparvainfectedcells